全文获取类型
收费全文 | 5501篇 |
免费 | 222篇 |
国内免费 | 85篇 |
专业分类
耳鼻咽喉 | 76篇 |
儿科学 | 32篇 |
妇产科学 | 609篇 |
基础医学 | 143篇 |
口腔科学 | 59篇 |
临床医学 | 266篇 |
内科学 | 575篇 |
皮肤病学 | 18篇 |
神经病学 | 74篇 |
特种医学 | 199篇 |
外科学 | 2966篇 |
综合类 | 184篇 |
现状与发展 | 1篇 |
预防医学 | 80篇 |
眼科学 | 4篇 |
药学 | 84篇 |
4篇 | |
中国医学 | 4篇 |
肿瘤学 | 430篇 |
出版年
2024年 | 8篇 |
2023年 | 215篇 |
2022年 | 383篇 |
2021年 | 417篇 |
2020年 | 456篇 |
2019年 | 215篇 |
2018年 | 284篇 |
2017年 | 132篇 |
2016年 | 224篇 |
2015年 | 221篇 |
2014年 | 440篇 |
2013年 | 363篇 |
2012年 | 333篇 |
2011年 | 324篇 |
2010年 | 288篇 |
2009年 | 197篇 |
2008年 | 177篇 |
2007年 | 188篇 |
2006年 | 143篇 |
2005年 | 119篇 |
2004年 | 101篇 |
2003年 | 100篇 |
2002年 | 92篇 |
2001年 | 88篇 |
2000年 | 63篇 |
1999年 | 60篇 |
1998年 | 38篇 |
1997年 | 18篇 |
1996年 | 25篇 |
1995年 | 26篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 7篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 7篇 |
排序方式: 共有5808条查询结果,搜索用时 443 毫秒
1.
2.
《European journal of surgical oncology》2019,45(6):931-940
BackgroundIsolated local recurrent or persistent esophageal cancer (EC) after curative intended definitive (dCRT) or neoadjuvant chemoradiotherapy (nCRT) with initially omitted surgery, is a potential indication for salvage surgery. We aimed to evaluate safety and efficacy of salvage surgery in these patients.Material and methodsA systematic literature search following PRISMA guidelines was performed using databases of PubMed/Medline. All included studies were performed in patients with persistent or recurrent EC after initial treatment with dCRT or nCRT, between 2007 and 2017. Survival analysis was performed with an inverse-variance weighting method.ResultsOf the 278 identified studies, 28 were eligible, including a total of 1076 patients. Postoperative complications after salvage esophagectomy were significantly more common among patients with isolated persistent than in those with locoregional recurrent EC, including respiratory (36.6% versus 22.7%; difference in proportion 10.9 with 95% confidence interval (CI) [3.1; 18.7]) and cardiovascular complications (10.4% versus 4.5%; difference in proportion 5.9 with 95% CI [1.5; 10.2]). The pooled estimated 30- and 90-day mortality was 2.6% [1.6; 3.6] and 8.0% [6.3; 9.8], respectively. The pooled estimated 3-year and 5-year overall survival (OS) were 39.0% (95% CI: [35.8; 42.2]) and 19.4% [95% CI:16.5; 22.4], respectively. Patients with isolated persistent or recurrent EC after initial CRT had similar 5-year OS (14.0% versus 19.7%, difference in proportion −5.7, 95% CI [-13.7; 2.3]).ConclusionsSalvage surgery is a potentially curative procedure in patients with locally recurrent or persistent esophageal cancer and can be performed safely after definitive or neoadjuvant chemoradiotherapy when surgery was initially omitted. 相似文献
3.
4.
《Journal of minimally invasive gynecology》2020,27(2):473-481
Study ObjectiveMONOFIX, a new absorbable barbed suture device, has a triangular stopper at the end to hold the suture to the tissue without hooking the looped end or knotting. The aim of this study was to compare the biomechanical strength and histologic features of MONOFIX with other barbed suture devices using a porcine model.DesignWell-designed, controlled trial without randomization.SettingAnimal laboratory in university hospital.SubjectsSixteen, 60-kg, mature female domestic pigs (skin closure group) and 5, 60-kg, mature female domestic pigs (fascial closure group).InterventionsIn the skin closure group, 3-0 MONOFIX versus 2 widely used 3-0 absorbable barbed sutures (3-0 V-Loc 180 or Stratafix). In the fascial closure group, 2-0 MONOFIX versus 1 widely used 2-0 absorbable barbed sutures (2-0 Stratafix).Measurements and Main ResultsIn the skin closure group, the biomechanical wound strength of skin sutured with size 3-0 MONOFIX, V-Loc 180, or Stratafix was evaluated by postoperative day assessment (days 0, 3, 7, 14, and 28). In the fascial closure group, pigs underwent 2 paramedian incisions and were sutured with 2-0 MONOFIX or with 2-0 Stratafix to evaluate histologic reaction. At 6 weeks the tissues around the suture line were excised and microscopically evaluated. The biomechanical strength of the MONOFIX had similar tissue tensile strength compared with the control, regardless of postoperative day. In the fascial closure model, there was no significant difference in the average tissue reaction score between MONOFIX and Stratafix (1.2 ± .3 vs 1.3 ± .3, p = .478).ConclusionThis study demonstrated that MONOFIX has equivalent tensile strength and histologic reaction when compared with commonly used barbed suture devices. Accordingly, this preclinical study suggests that the use of MONOFIX is a safe alternative to other barbed suture devices. 相似文献
5.
6.
7.
8.
9.
10.